Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
2,868
+11
+0.4% +$5.08K 0.12% 290
2026
Q1
$1.37M Buy
2,857
+2,175
+319% +$1.11M 0.14% 240
2025
Q4
$383K Sell
682
-2,067
-75% -$1.17M 0.05% 455
2025
Q3
$1.41M Buy
+2,749
New +$1.2M 0.2% 152
2024
Q2
Sell
-2,103
Closed -$850K 384
2024
Q1
$850K Buy
+2,103
New +$739K 0.37% 98

Other funds holding MEDP

Numerai's MEDP Position: Q2 2026 in Review

Numerai increased its Medpace (MEDP) stake by 0.39% in Q2 2026, buying an estimated $5.08K and bringing the position to 2,868 shares worth $1.52M. The position accounts for 0.12% of the portfolio, ranked #290.

Numerai first reported a position in MEDP in Q1 2024 and has held it in 5 quarters since. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Numerai held 2,868 shares of Medpace worth $1.52M as of Q2 2026.
  • Numerai bought 11 Medpace shares in Q2 2026, an estimated $5.08K.
  • Medpace made up 0.12% of Numerai's portfolio in Q2 2026, its #290 holding.
  • Numerai first reported a position in Medpace in Q1 2024 and has held it in 5 quarters since.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.